Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET.
Sign Up to like & getrecommendations! Published in 2017 at "Lung cancer"
DOI: 10.1016/j.lungcan.2016.05.025
Abstract: Non-small cell lung cancer (NSCLC) therapy has entered a rapidly advancing era of precision medicine with an ever increasing number of drugs directed against a variety of specific tumor targets. Amongst these new agents, tyrosine… read more here.
Keywords: pet; tki pet; immuno pet; personalizing nsclc ... See more keywords